サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1772250

オルソバイオロジクスの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2033年

Orthobiologics Market Size, Share & Trends Analysis Report By Product (DBM, Allograft, BMP, Viscosupplementation), By Application (Spinal Fusion, Trauma Repair), By End Use, By Region, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
オルソバイオロジクスの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2033年
出版日: 2025年06月24日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

オルソバイオロジクス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の整形生物製剤市場規模は2033年までに103億4,000万米ドルに達し、2025～2033年にかけてCAGR 4.74％で拡大すると推定されています。

世界中で整形外科手術の症例が増加していることが、整形生物製剤の需要を促進しています。米国整形外科学会（AAOS）2023年次総会で発表された研究では、整形外科医が人工関節全置換術（TJA）の需要増に対応するという課題に直面することが明らかになりました。この調査によると、需要に対応するためには、外科医はTJAの症例数を2倍にするか、5年ごとに外科医の数を10％増やす必要があるといいます。

ヘルスケアの進歩と患者の転帰への注目が高まる中、世界各国の政府は、整形生物製剤の成長を促進するための施策やイニシアチブを実施しています。例えば、米国整形外科学会（AAOS）は、透明で科学的な方法で筋骨格系ケアを改善することに取り組んでいます。2020年10月、AAOSはウェブサイトに生物製剤ダッシュボードを開設し、整形外科医が生物製剤を用いた治療法の承認状況を把握できるようにしました。このイニシアチブはAAOS Biologics Initiativeの一部であり、筋骨格系の健康コミュニティにエビデンスに基づいたガイダンスを提供するものです。この取り組みの一環として、AAOS理事会は生物製剤に関連する2つのポジションステートメントも改訂しました。

世界中で高齢者が増加していることも、整形外科手術の需要を押し上げると予想されています。India Ageing Report 2023によると、インドの高齢者は急速なペースで増加しており、10年ごとの増加率は41％です。2050年までに、インドの人口の20％以上が高齢者になると予想されています。高齢になると、骨粗しょう症、変形性関節症、骨折など、筋肉や骨に問題が生じる可能性が高くなります。その結果、整形生物製剤に対するニーズが高まります。

さらに、交通事故事例の増加が市場の成長を補完すると予想されています。米国道路交通安全局の報告によると、2023年上半期の自動車事故による死亡者数は推定1万9,515人でした。これは、死亡者数が2万190人であった前年同期に比べ、約3.3％減少したことになります。また、2023年第1四半期、第2四半期ともに死亡者数は減少しています。このように、負傷者数の増加は、整形生物製剤の需要を増加させると予想されます。

同市場で事業を展開する主要企業は、製品形成とリーチの拡大に重点を置き、提携、供給契約、パートナーシップなどの戦略を採用しています。例えば、2023年9月、HippoFi Inc.はZimmer Biomet Holdings Inc.と提携し、骨成長のための合成生体材料を発表しました。この生体材料は、2024年にHippoFiの生物製剤子会社PUR Biologicsの下で発売される予定です。

生物製剤市場のハイライト

  • 製品別では、関節内補充療法セグメントが2024年のオルソバイオロジクス市場を独占し、42.21%の最大売上シェアを占めました。これは、生活習慣病関連の有病率の増加とヒアルロン酸療法開発の進歩によるものです。
  • 用途別では、変性椎間板疾患の罹患率の上昇により、脊椎固定術セグメントが2024年に48.29%以上の最大収益シェアを占めました。
  • 最終用途別では、外科手術を受ける患者人口の増加により、病院セグメントが2024年に75％超の収益シェアを占め、生物製剤産業を支配しました。
  • 北米は2024年に整形生物工学市場を独占し、46.03%の最大の収益シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 オルソバイオロジクス市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • オルソバイオロジクス：市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析
  • 規制の枠組み
  • 整形外科疾患の有病率
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 整形外科産業の主要利害関係者による取り組み
  • 整形外科産業の資金調達市場
    • 整形外科企業10社が2024年第1四半期に新たな資金調達ラウンドを完了
    • 資金調達のお知らせ

第4章 オルソバイオロジクス市場セグメント分析、製品別、2021～2033年

  • 定義と範囲
  • 製品市場シェア分析、2021年と2033年
  • セグメントダッシュボード
  • 世界のオルソバイオロジクス市場（製品別、2021～2033年）
  • 脱灰骨基質（DBM）
    • 脱灰骨基質（DBM）市場推定・予測、2021～2033年
  • 同種移植
    • 同種移植市場推定・予測、2021～2033年
  • 骨形成タンパク質（BMP）
    • 骨形成タンパク質（BMP）市場推定・予測、2021～2033年
  • 関節内補充療法
    • 関節内補充療法市場推定・予測、2021～2033年
  • 合成骨代替物
    • 合成骨代替物市場推定・予測、2021～2033年
  • 幹細胞療法
    • 幹細胞療法市場推定・予測、2021～2033年

第5章 オルソバイオロジクス市場セグメント分析、用途別、2021～2033年

  • 定義と範囲
  • 用途市場シェア分析、2021年と2033年
  • セグメントダッシュボード
  • 世界のオルソバイオロジクス市場（用途別、2021～2033年）
  • 脊椎固定
    • 脊椎固定市場推定・予測、2021～2033年
  • 外傷修復
    • 外傷修復市場推定・予測、2021～2033年
  • 再建手術
    • 再建手術市場推定・予測、2021～2033年

第6章 オルソバイオロジクス市場セグメント分析、最終用途別、2021～2033年

  • 定義と範囲
  • 最終用途市場シェア分析、2021年と2033年
  • セグメントダッシュボード
  • 世界のオルソバイオロジクス市場（最終用途別、2021～2033年）
  • 病院
    • 病院市場推定・予測、2021～2033年
  • 整形外科クリニック
    • 整形外科クリニック市場推定・予測、2021～2033年

第7章 オルソバイオロジクス市場セグメント分析、地域別、製品別、用途別、最終用途別、2021～2033年

  • 地域別市場シェア分析、2021年と2033年
  • 地域別市場ダッシュボード
  • 地域市場のスナップショット
  • 地域別オルソバイオロジクス市場シェア、2021年と2033年
  • 北米
    • 北米のオルソバイオロジクス市場、2021～2033年
    • 米国
    • カナダ
  • 欧州
    • 欧州のオルソバイオロジクス市場、2021～2033年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業プロファイル
    • Medtronic Plc
    • DePuy Synthes
    • Zimmer Biomet
    • Stryker Corporation
    • Bioventus LLC
    • Seaspine Holdings Corporation
    • Orthofix, Inc.
    • Globus Medical
    • Arthrex, Inc.
    • Bone Biologics Corp.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global orthobiologics market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 5 Global orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 6 Global orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 7 North America orthobiologics market, by region, 2021 - 2033 (USD Million)
  • Table 8 North America orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 9 North America orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 10 North America orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 11 U.S. orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 12 U.S. orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 13 U.S. orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 14 Canada orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 15 Canada orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 16 Canada orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 17 Europe orthobiologics market, by region, 2021 - 2033 (USD Million)
  • Table 18 Europe orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 19 Europe orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 20 Europe orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 21 Germany orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 22 Germany orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 23 Germany orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 24 UK orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 25 UK orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 26 UK orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 27 France orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 28 France orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 29 France orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 30 Italy orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 31 Italy orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 32 Italy orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Spain orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 34 Spain orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 35 Spain orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 36 Denmark orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 37 Denmark orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 38 Denmark orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Sweden orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 40 Sweden orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 41 Sweden orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 42 Norway orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 43 Norway orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 44 Norway orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific orthobiologics market, by region, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 49 China orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 50 China orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 51 China orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 52 Japan orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 53 Japan orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 54 Japan orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 55 India orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 56 India orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 57 India orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 58 South Korea orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 59 South Korea orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 60 South Korea orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Australia orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 62 Australia orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 63 Australia orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 64 Thailand orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 65 Thailand Orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 66 Thailand Orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 67 Latin America orthobiologics market, by region, 2021 - 2033 (USD Million)
  • Table 68 Latin America orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 69 Latin America orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 70 Latin America orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 71 Brazil orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 72 Brazil orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 73 Brazil orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 74 Mexico orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 75 Mexico orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 76 Mexico orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 77 Argentina orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 78 Argentina orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 79 Argentina orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 80 MEA orthobiologics market, by region, 2021 - 2033 (USD Million)
  • Table 81 MEA orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 82 MEA orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 83 MEA orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 84 South Africa orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 85 South Africa orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 86 South Africa orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 90 UAE orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 91 UAE orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 92 UAE orthobiologics market, by end use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait orthobiologics market, by product, 2021 - 2033 (USD Million)
  • Table 94 Kuwait orthobiologics market, by application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait orthobiologics market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Orthobiologics market: outlook
  • Fig. 9 Orthobiologics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Orthobiologics market driver impact
  • Fig. 12 Orthobiologics market restraint impact
  • Fig. 13 Porter's Analysis
  • Fig. 14 PESTLE Analysis
  • Fig. 15 Orthobiologics market: Product movement analysis
  • Fig. 16 Orthobiologics market: Product outlook and key takeaways
  • Fig. 17 Demineralized bone matrix (DBM) market estimates and forecast, 2021 - 2033
  • Fig. 18 Allograft estimates and forecast, 2021 - 2033
  • Fig. 19 Bone morphogenetic protein (BMP) estimates and forecast, 2021 - 2033
  • Fig. 20 Viscosupplementation estimates and forecast, 2021 - 2033
  • Fig. 21 Synthetic bone substitutes estimates and forecast, 2021 - 2033
  • Fig. 22 Stem cell therapy estimates and forecast, 2021 - 2033
  • Fig. 23 Orthobiologics Market: Application Movement Analysis
  • Fig. 24 Orthobiologics market: Application outlook and key takeaways
  • Fig. 25 Spinal fusion market estimates and forecasts, 2021 - 2033
  • Fig. 26 Trauma repair market estimates and forecasts, 2021 - 2033
  • Fig. 27 Reconstructive surgery market estimates and forecasts, 2021 - 2033
  • Fig. 28 Orthobiologics market: End use movement analysis
  • Fig. 29 Orthobiologics market: End use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecasts, 2021 - 2033
  • Fig. 31 Orthopedic Clinics market estimates and forecasts, 2021 - 2033
  • Fig. 32 Global orthobiologics market: Regional movement analysis
  • Fig. 33 Global orthobiologics market: Regional outlook and key takeaways
  • Fig. 34 North America orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 35 Key country dynamics
  • Fig. 36 U.S. orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 39 Europe orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Spain orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 46 Key country dynamics
  • Fig. 47 France orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Norway orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Sweden orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 56 Asia Pacific orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 59 Key country dynamics
  • Fig. 60 China orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 61 Key country dynamics
  • Fig. 62 India orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 69 Latin America orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Brazil orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Mexico orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Argentina orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 76 MEA orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Africa orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Saudi Arabia orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 81 Key country dynamics
  • Fig. 82 UAE orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Kuwait orthobiologics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 85 Key company categorization
  • Fig. 86 Heat map analysis, 2021 - 2033
目次
Product Code: GVR-1-68038-360-7

Orthobiologics Market Growth & Trends:

The global orthobiologics market size is estimated to reach USD 10.34 billion by 2033, expanding at a CAGR of 4.74% from 2025 to 2033, according to a new report by Grand View Research, Inc. Increasing cases of orthopedic surgeries across the globe is driving the demand for orthobiologics. A study presented at the Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) 2023, revealed that orthopedic surgeons would face a challenge in meeting the increasing demand for total joint arthroplasty (TJA). The study found that to keep up with the demand, surgeons will have to either double their TJA caseload or increase the number of surgeons by 10% every five years.

With an increasing focus on healthcare advancements and patient outcomes, governments worldwide are implementing policies and initiatives to foster the growth of orthobiologics. For instance, the American Academy of Orthopedic Surgeons (AAOS) is committed to improving musculoskeletal care in a transparent and scientific way. In October 2020, the AAOS launched the Biologics Dashboard on their website, which is designed to assist orthopedic surgeons in keeping track of the approval status of biologic-based interventions. This initiative is a part of the AAOS Biologics Initiative, which offers evidence-based guidance to the musculoskeletal health community. As part of this effort, the AAOS Board of Directors also revised two position statements related to biologics.

Increasing geriatric population across the globe is also anticipated to boost the demand for orthopedic surgeries. According to the India Ageing Report 2023, country's elderly population is growing at a rapid pace, with a decadal growth rate of 41%. By 2050, over 20% of India's population will be elderly citizens.As people age, they are more likely to experience issues with their muscles and bones, such as osteoporosis, osteoarthritis, and fractures. This results in a greater need for orthobiologics solutions.

Moreover, increasing cases of road accidents is anticipated to supplement the market growth. According to the National Highway Traffic Safety Administration report, there were an estimated 19,515 deaths in motor vehicle accidents during the first half of 2023. This represents a decrease of about 3.3% compared to the same period in the previous year, which had 20,190 fatalities. The report also shows that fatalities decreased during both the first and second quarters of 2023. Thus, the increasing number of injured populations is expected to increase the demand for orthobiologics.

The major players operating in the market are adopting strategies such as collaborations, supply agreements, and partnerships with a major focus on enhancing the product formation and reach. For instance, inSeptember 2023, HippoFi Inc. partnered with Zimmer Biomet Holdings Inc. to bring forth a synthetic biomaterial for bone growth. The biomaterial will be launched under HippoFi's biologic subsidiary, PUR Biologics in 2024.

Orthobiologics Market Report Highlights:

  • Based on product, the viscosupplementation segment dominated the orthobiologics market in 2024 and accounted for the largest revenue share of 42.21% owing to the increasing prevalence of lifestyle-related conditions and advances in hyaluronic acid therapy development
  • Based on application, the spinal fusion segment held the largest revenue share of over 48.29% in 2024 owing to the rising incidence of degenerative disc disease
  • Based on end-use, the hospitals segment dominated the orthobiologics industry in 2024 with a revenue share of over 75% due to the growing patient population undergoing surgical procedures
  • North America dominated the orthobiologics market in 2024 and accounted for the largest revenue share of 46.03%

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Orthobiologics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing number of sports injuries and road traffic accidents
      • 3.2.1.2. Increasing adoption of minimally invasive treatments
      • 3.2.1.3. Increasing reimbursement coverage for orthopedic procedures
      • 3.2.1.4. Growing aging population and increase in chronic diseases
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Availability of alternative treatments
      • 3.2.2.2. Stringent regulatory framework
  • 3.3. Orthobiologics: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Framework
  • 3.5. Orthopedic Disease Prevalence
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East and Africa
  • 3.6. Initiatives by key stakeholders in the Orthopedic Industry
  • 3.7. Orthopedic Industry Funding Market
    • 3.7.1. 10 Orthopedic Companies Close New Funding Rounds in 1Q24 Funding
    • 3.7.2. Funding Announcements

Chapter 4. Orthobiologics Market Segment Analysis, By Product, 2021-2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Type Market Share Analysis, 2021 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Orthobiologics Market, by Product Type, 2021 to 2033
  • 4.5. Demineralized Bone Matrix (DBM)
    • 4.5.1. Demineralized Bone Matrix (DBM) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Allograft
    • 4.6.1. Allograft market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Bone morphogenetic protein (BMP)
    • 4.7.1. Bone morphogenetic protein (BMP) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8. Viscosupplementation
    • 4.8.1. Viscosupplementation market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.9. Synthetic bone substitutes
    • 4.9.1. Synthetic bone substitutes market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.10. Stem cell therapy
    • 4.10.1. Stem cell therapy market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Orthobiologics Market Segment Analysis, By Application, 2021-2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2021 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global orthobiologics Market, by Application, 2021 to 2033
  • 5.5. Spinal Fusion
    • 5.5.1. Spinal fusion market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Trauma repair
    • 5.6.1. Trauma repair market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Reconstructive surgery
    • 5.7.1. Reconstructive surgery market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Orthobiologics Market Segment Analysis, By End Use, 2021-2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2021 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Orthobiologics Market, by end use, 2021 to 2033
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Orthopedic Clinics
    • 6.6.1. Orthopedic Clinics market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Orthobiologics Market Segment Analysis, By Region, By Product, By Application, By End Use, 2021- 2033 (USD Million)

  • 7.1. Regional Market Share Analysis, 2021 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Orthobiologics Market Share by Region, 2021 & 2033:
  • 7.5. North America
    • 7.5.1. North America orthobiologics market, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. U.S. orthobiologics market, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Canada orthobiologics market, 2021 - 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. UK orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Germany orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. France orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Italy orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Spain orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Norway orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Sweden orthobiologics market, 2021 - 2033 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Denmark orthobiologics market, 2021 - 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Japan orthobiologics market, 2021 - 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. China orthobiologics market, 2021 - 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. India orthobiologics market, 2021 - 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Australia orthobiologics market, 2021 - 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea orthobiologics market, 2021 - 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Thailand orthobiologics market, 2021 - 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Brazil orthobiologics market, 2021 - 2033 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Mexico orthobiologics market, 2021 - 2033 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Argentina orthobiologics market, 2021 - 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. South Africa orthobiologics market, 2021 - 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Saudi Arabia orthobiologics market, 2021 - 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. UAE orthobiologics market, 2021 - 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Kuwait orthobiologics market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Profiles
    • 8.3.1. Medtronic Plc
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. DePuy Synthes
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Zimmer Biomet
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Stryker Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bioventus LLC
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Seaspine Holdings Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Orthofix, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Globus Medical
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Arthrex, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Bone Biologics Corp.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives